NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tirzepatide from Hangzhou Mandy Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
73%
Finnrick rating
#234 of 281 Tirzepatide vendors
9 of 13 classifiable tests passed
natural 69% · customers 4.7★ (14)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Repeated purity misses, including 93.01% and a recent 96.1% after several 99.6–99.9% results, keep this Tirzepatide profile below cleaner peers. Batch IDs are thin, and an endotoxin-only positive sits outside this score.

methodology →
vendor intelligence report
Vendor Intelligence Report: Hangzhou Mandy Biotechnology

Corporate records support a real Hangzhou biotech entity, but domain history and archived pages point to a later peptide pivot. A Seychelles B2B trail tied to the site markets precursor chemicals, while channel and payment rails leave the seller hard to pin down.

23 pages9 risk factors assessed2 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%25 Nov 2025: 74%1 Jan 2026: 76%15 Jan 2026: 78%15 Jan 2026: 79%13 Feb 2026: 80%26 Feb 2026: 75%3 Mar 2026: 76%4 Mar 2026: 72%25 Mar 2026: 73%28 Apr 2026: 75%25 May 2026: 76%17 Jun 2026: 77%10 Nov 2026: 73%15 Nov 2026: current 73%74%75%73%Nov 25Nov 26
Showing Tirzepatide tests only
Peptide testing

Ordered Tirzepatide from Hangzhou Mandy Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
Hangzhou Mandy Biotechnology Tirzepatide test history
COA-backed lab tests
1-10 of 14

About Hangzhou Mandy Biotechnology test results from Finnrick

Hangzhou Mandy Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 39 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Hangzhou Mandy Biotechnology peptides in this dataset are BPC-157 (5 tests), GHK-Cu (6 tests) and Retatrutide (14 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 39 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Tirzepatide from Hangzhou Mandy Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply